Cancer
Conditions
Interventions
Oral Food for Special Medical Purposes Group (Tumor-Specific Complete Nutrition Formulas):None
Control group:None
Sponsors
Yunnan Provincial Tumor Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Only patients who meet all the following enrollment criteria can be included in this study: 1) Aged 18-80 years, regardless of gender; 2) Patients with solid tumors scheduled to receive at least 4 cycles of chemotherapy, and those planned to receive combined with other systemic anti-tumor therapies are allowed to enroll; 3) Patients assessed as having malnutrition or at risk of malnutrition (score >=3) by nutritionists using the Nutritional Risk Screening 2002 (NRS2002); 4) Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) score of 0-2; 5) Voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: Patients with any of the following conditions will be excluded from this study: 1) Concurrent multiple primary tumors; 2) Having taken nutritional supplements or drugs containing immunomodulatory formulas (with an average daily intake of DHA + EPA = 500 mg/d, or containing arginine or glutamine) within 1 month; 3) Patients with complicated active infections (such as sepsis) or severe diseases such as cognitive impairment caused by neurological or mental diseases, severe hematological diseases, severe digestive tract diseases, etc.; 4) Pregnant or lactating women; 5) Patients who cannot receive treatment on time, cannot cooperate with follow-up, or have difficulty taking oral nutritional formulas; 6) Patients known to be allergic to the active ingredients of the total nutritional formula food for special medical purposes in oncology, or patients judged by researchers to be unsuitable for using Suyisu; 7) Patients participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemotherapy Completion Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Non-Antineoplastic Medical Costs;Patient Out-of-Pocket Payment;Weight Change Percentage;Chemotherapy Dose Reduction Rate;Quality of Life;Treatment-Related AEs;Medical insurance covers non-anti-tumor treatment expenses;Total Treatment Cost;Chemotherapy Delay Rate;Weight Change;Adverse Events;Standard-Dose Chemotherapy Completion Rate; | — |
Countries
China
Contacts
Public ContactLi Gaofeng
Yunnan Provincial Tumor Hospital
Outcome results
None listed